Inflammation
|
0.600 |
Biomarker
|
phenotype |
CTD_human |
Association of ankle-arm index with inflammation and mineral bone disorder in hemodialysis patients.
|
21437516 |
2011 |
Inflammation
|
0.600 |
Biomarker
|
phenotype |
RGD |
The effects of C-reactive protein, interleukin-6, and tumor necrosis factor-alpha in rat allograft adventitial inflammation and allograft arteriosclerosis.
|
19917410 |
2009 |
Inflammation
|
0.600 |
Biomarker
|
phenotype |
LHGDN |
C-reactive protein and coronary calcium score association in coronary artery disease.
|
18810717 |
2008 |
Inflammation
|
0.600 |
Biomarker
|
phenotype |
LHGDN |
Impact of metabolic syndrome on the long-term survival of patients with acute myocardial infarction: potential association with C-reactive protein.
|
18296838 |
2008 |
Inflammation
|
0.600 |
Biomarker
|
phenotype |
LHGDN |
Procalcitonin fails to differentiate inflammatory status or predict long-term outcomes in peritoneal dialysis-associated peritonitis.
|
18556380 |
2008 |
Inflammation
|
0.600 |
Biomarker
|
phenotype |
LHGDN |
C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) are common measures of systemic inflammation.
|
18078625 |
2008 |
Inflammation
|
0.600 |
Biomarker
|
phenotype |
LHGDN |
Similar to C-reactive protein (CRP), it may be another marker of systemic inflammation.
|
18605934 |
2008 |
Inflammation
|
0.600 |
Biomarker
|
phenotype |
LHGDN |
Association between markers of renal function and C-reactive protein level in the elderly: confounding by functional status.
|
18609082 |
2008 |
Inflammation
|
0.600 |
Biomarker
|
phenotype |
LHGDN |
High-sensitivity C-reactive protein is independently associated with early carotid artery progression in women but not in men: the INVADE Study.
|
17885262 |
2007 |
Inflammation
|
0.600 |
Biomarker
|
phenotype |
LHGDN |
Serum amyloid P and cardiovascular disease in older men and women: results from the Cardiovascular Health Study.
|
17138933 |
2007 |
Inflammation
|
0.600 |
AlteredExpression
|
phenotype |
LHGDN |
Recently, highly sensitive C-reactive protein (hs-CRP) assays have become available for detecting small changes in CRP levels within the reference range, allowing for the evaluation of clinical inflammation.
|
17650829 |
2007 |
Inflammation
|
0.600 |
Biomarker
|
phenotype |
LHGDN |
C-reactive protein and low albumin are predictors of morbidity and cardiovascular events in chronic kidney disease (CKD) 3-5 patients.
|
17598370 |
2007 |
Inflammation
|
0.600 |
Biomarker
|
phenotype |
LHGDN |
C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells: implications for clinical and subclinical atherosclerosis.
|
16580524 |
2006 |
Inflammation
|
0.600 |
GeneticVariation
|
phenotype |
LHGDN |
Genetic polymorphisms and the risk of stroke after cardiac surgery.
|
16051899 |
2005 |
Inflammation
|
0.600 |
Biomarker
|
phenotype |
CTD_human |
Effectiveness of the concomitant use of bivalirudin and drug-eluting stents (from the prospective, multicenter BivAlirudin and Drug-Eluting STents [ADEST] study).
|
16125490 |
2005 |
Inflammation
|
0.600 |
Biomarker
|
phenotype |
LHGDN |
For clinicians plasma C-reactive protein (CRP) levels are the only widely available tests that provide a tangible link between inflammation and atherosclerosis.
|
15306744 |
2004 |
Inflammation
|
0.600 |
Biomarker
|
phenotype |
CTD_human |
Therapy of ischemic cardiomyopathy with the immunomodulating agent pentoxifylline: results of a randomized study.
|
14970111 |
2004 |
Inflammation
|
0.600 |
Biomarker
|
phenotype |
LHGDN |
Binding of C-reactive protein to modified low-density-lipoprotein particles: identification of cholesterol as a novel ligand for C-reactive protein.
|
12102655 |
2002 |
Inflammation
|
0.600 |
Biomarker
|
phenotype |
LHGDN |
The acute-phase reactant C-reactive protein (CRP) has been shown to reflect systemic and, perhaps, vascular inflammation and to predict future cardiovascular events in asymptomatic individuals.
|
12213988 |
2001 |